Market Place
Sourcing Support
Dr. Stephen Fisher Joins Anivive Board Of Directors
15 Oct 2025 //
PR NEWSWIRE BIO
Anivive`s Dr. Edward Robb Presents Valley Fever Vaccine Research
09 May 2025 //
PR NEWSWIRE
GC376 Nominated by AVMA and FelineVMA to FDA`s Bulk Drug List
18 Feb 2025 //
PR NEWSWIRE
Anivive Completes LAVERDIA-CA1 Pivotal Study For Canine Lymphoma
14 Feb 2025 //
PR NEWSWIRE
Kevin McCarthy Appointed To Anivive`s Board Of Directors
21 Oct 2024 //
PR NEWSWIRE
Anivive Receives $33M NIAID Contract For Valley Fever Vaccine
02 Aug 2024 //
PR NEWSWIRE
Anivive to Present Research on First Systemic Antifungal Vaccine at WVC
04 Apr 2024 //
PR NEWSWIRE
Anivive Sponsors National Academy of Sciences Valley Fever Workshop
16 Nov 2022 //
PRNEWSWIRE
Anivive Licenses Novel Canine Cancer Therapeutic to Expand Sales & Pipeline
12 Jan 2022 //
PRNEWSWIRE
Anivive Expands Specialty Sales Team
29 Jun 2021 //
PR NEWSWIRE
Anivive Expands Sales Team to Support National Distribution of LAVERDIA™-CA1
28 Jun 2021 //
PR NEWSWIRE
Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians
26 May 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.